Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
US Army
AstraZeneca
Boehringer Ingelheim
Covington
US Department of Justice
Johnson and Johnson
Citi

Generated: June 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin lispro recombinant

« Back to Dashboard

insulin lispro recombinant

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Lilly HUMALOG insulin lispro recombinant INJECTABLE;INJECTION 020563 NDA Eli Lilly and Company N 0002-7510-01
Lilly HUMALOG insulin lispro recombinant INJECTABLE;INJECTION 020563 NDA Eli Lilly and Company N 0002-7510-17
Lilly HUMALOG insulin lispro recombinant INJECTABLE;INJECTION 020563 NDA Eli Lilly and Company N 0002-7510-99
Lilly HUMALOG insulin lispro recombinant INJECTABLE;INJECTION 020563 NDA Eli Lilly and Company N 0002-7516-59
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Citi
Baxter
US Department of Justice
QuintilesIMS
Accenture
Johnson and Johnson
McKesson
Queensland Health